Perspective Therapeutics, Inc.
US ˙ NYSEAM

SecurityCATX / Perspective Therapeutics, Inc.
InstitutionWealth Effects Llc
Latest Disclosed Ownership33,000 shares
Latest Disclosed Value $ 137,610
Wealth Effects Llc reports 32.00% increase in ownership of CATX / Perspective Therapeutics, Inc.

On April 21, 2026 - Wealth Effects Llc filed a 13F-HR form disclosing ownership of 33,000 shares of Perspective Therapeutics, Inc. (US:CATX) valued at $137,610 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 25,000 shares of Perspective Therapeutics, Inc.. This represents a change in shares of 32.00% during the quarter. The current value of the position is $107,250 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F PERSPECTIVE THERAPEUTICS COM NEW 46489V302 33,000 8,000 32.00 138 101.47 0.0488
2026-01-26 2025-12-31 13F PERSPECTIVE THERAPEUTICS COM NEW 46489V302 25,000 -1,000 -3.85 69 -23.60 0.0215
2025-10-28 2025-09-30 13F PERSPECTIVE THERAPEUTICS COM NEW 46489V302 26,000 2,000 8.33 89 8.54 0.0287
2025-07-15 2025-06-30 13F PERSPECTIVE THERAPEUTICS COM NEW 46489V302 24,000 -15,000 -38.46 83 -1.20 0.0309
2025-04-23 2025-03-31 13F PERSPECTIVE THERAPEUTICS COM NEW 46489V302 39,000 1,000 2.63 83 -31.40 0.0349
2025-01-22 2024-12-31 13F PERSPECTIVE THERAPEUTICS COM NEW 46489V302 38,000 24,750 186.79 121 -31.25 0.0431
2024-10-21 2024-09-30 13F PERSPECTIVE THERAPEUTICS COM NEW 46489V302 13,250 -4,100 -23.63 177 2.33 0.0620
2024-08-02 2024-06-30 13F PERSPECTIVE THERAPEUTICS COM NEW 46489V302 17,350 17,350 173 0.0627
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.